| scholarly article | Q13442814 |
| P50 | author | Eugenia Cifuentes-Pagano | Q55686236 |
| Daniel N Meijles | Q57247139 | ||
| P2093 | author name string | P J Pagano | |
| C Castro | |||
| C Amaya | |||
| A Lucero | |||
| I M Quesada | |||
| P2860 | cites work | Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression | Q46937236 |
| Does NADPH Oxidase Deficiency Cause Artery Dilatation in Humans? | Q58420797 | ||
| Reduced Atherosclerotic Burden in Subjects With Genetically Determined Low Oxidative Stress | Q58420809 | ||
| Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis | Q80234311 | ||
| Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery | Q80444056 | ||
| Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway | Q83431808 | ||
| Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice | Q24568215 | ||
| The role of monocytes in angiogenesis and atherosclerosis | Q26820243 | ||
| NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS | Q26821775 | ||
| Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture | Q28212820 | ||
| p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice | Q28364478 | ||
| The vasa vasorum in diseased and nondiseased arteries | Q33656008 | ||
| Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques | Q33737346 | ||
| Protection against vascular aging in Nox2-deficient mice: Impact on endothelial progenitor cells and reparative neovascularization | Q34289652 | ||
| Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors | Q34389230 | ||
| Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation | Q34627341 | ||
| Assessment of atherosclerosis in chronic granulomatous disease | Q34650014 | ||
| Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1α activation: a novel aspect of angiogenesis in atherosclerosis | Q35101457 | ||
| Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1. | Q35379312 | ||
| Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2 | Q35486123 | ||
| Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets | Q35992729 | ||
| Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. | Q36617730 | ||
| Plaque neovascularization and antiangiogenic therapy for atherosclerosis | Q36832810 | ||
| The dynamic vasa vasorum | Q36881789 | ||
| Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions | Q37216851 | ||
| Mechanisms of oxidative stress in human aortic aneurysms--association with clinical risk factors for atherosclerosis and disease severity | Q37286501 | ||
| The vicious circle between oxidative stress and inflammation in atherosclerosis. | Q37334949 | ||
| Role of NADPH oxidase in atherosclerosis | Q37445914 | ||
| Biomarkers of inflammation and oxidative stress in atherosclerosis. | Q37765284 | ||
| Inflammation and atherosclerosis: direct versus indirect mechanisms | Q38077322 | ||
| Inflammation and immune system interactions in atherosclerosis | Q38083555 | ||
| Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling | Q38116706 | ||
| Current status of NADPH oxidase research in cardiovascular pharmacology | Q38132120 | ||
| Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery | Q39643032 | ||
| Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization | Q40174095 | ||
| Chemokine Lkn-1/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cells | Q42924847 | ||
| Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study | Q43266789 | ||
| Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. | Q43726340 | ||
| Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. | Q44028496 | ||
| NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy | Q44362025 | ||
| Vascular endothelial growth factor and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with plaque destabilization via neovascularization | Q44981162 | ||
| Cell-free assays: the reductionist approach to the study of NADPH oxidase assembly, or "all you wanted to know about cell-free assays but did not dare to ask". | Q46614435 | ||
| NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice | Q46843176 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 469-475 | |
| P577 | publication date | 2015-08-08 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques | |
| P478 | volume | 242 |
| Q42934568 | Clarity on the Isoform-Specific Roles of NADPH Oxidases and NADPH Oxidase-4 in Atherosclerosis |
| Q33885504 | Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease |
| Q90282397 | Identification of highly potent and selective inhibitor, TIPTP, of the p22phox-Rubicon axis as a therapeutic agent for rheumatoid arthritis |
| Q49422978 | NADPH Oxidase Deficiency: A Multisystem Approach |
| Q88487528 | Reactive Oxygen Species in Metabolic and Inflammatory Signaling |
| Q37631526 | Sailuotong Prevents Hydrogen Peroxide (H₂O₂)-Induced Injury in EA.hy926 Cells |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q39028636 | The Pathophysiological Role of NOX2 in Hypertension and Organ Damage |
Search more.